投資有価証券、保険差益、繰延税金負債他1件
- 【期間】
| 年度 | 投資有価証券 | 保険差益 | 繰延税金負債 | 研究開発費 |
|---|
| 2008/03 | 4.27億 | | - | | - | | - | |
| 2009/03 | 3.37億 | -21% | - | | - | | - | |
| 2010/03 | 3.92億 | +16.1% | - | | - | | - | |
| 2011/03 | 3.41億 | -12.9% | - | | - | | - | |
| 2012/03 | 3.63億 | +6.3% | - | | - | | - | |
| 2013/03 | 5.37億 | +48.2% | - | | - | | 243百万 | |
| 2014/03 | 5.3億 | -1.3% | - | | 47百万 | | 284百万 | +17.2% |
| 2015/03 | 6.92億 | +30.6% | - | | 95百万 | +102.6% | 276百万 | -3% |
| 2016/03 | 8.55億 | +23.5% | - | | 140百万 | +46.4% | 277百万 | +0.5% |
| 2017/03 | 8.53億 | -0.2% | -1.3百万 | | 142百万 | +1.9% | 287百万 | +3.7% |
| 2018/03 | 10.6億 | +24.3% | - | | 201百万 | +41.4% | 295百万 | +2.7% |
| 2019/03 | 9.23億 | -13% | - | | - | | 320百万 | +8.5% |
| 2020/03 | 6.99億 | -24.3% | - | | - | | 357百万 | +11.6% |
| 2021/03 | 8.33億 | +19.2% | - | | - | | 381百万 | +6.7% |
| 2022/03 | 8.19億 | -1.7% | - | | - | | 368百万 | -3.4% |
| 2023/03 | 8.51億 | +3.9% | - | | - | | 425百万 | +15.5% |
| 2024/03 | 12.5億 | +46.4% | - | | - | | 443百万 | +4.2% |
